Organization | Atlantic Research Group

Atlantic Research Group Report issue

Foundation Phase 1 Phase 3

Founded: Charlottesville VA United States (2004)

Organization Overview

First Clinical Trial

2011

NCT01406470

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Atlantic Research Group

Active Ingredients

Drugs in Phase 3 Trials (3)

antihemophilic factor viii human (Hemofil M) (1 trial)

antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)

immune globulin (human) (Gamastan) (2 trials)

Drugs in Phase 1 Trials (1)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hemophilia A (Phase 3)

Immunologic Deficiency Syndromes (Phase 3)

Neoplasms (Phase 1)

Overview

Highest Phase: Phase 3
# of Trials: 5
# of Trial APIs: 4